NCT02222961View on ClinicalTrials.gov

Single Increasing Dose Followed by Maintenance Dose Tolerance Study of BIIR 561 CL in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 30, 1999

Primary Completion Date

June 30, 2000

Conditions
Healthy
Interventions
DRUG

BIIR 561 CL

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY